Eurogin 2003 - Paris 13-16 April 2003

SCIENTIFIC PROGRAMME

Sunday 13 April I Monday 14 April I Tuesday 15 April I Wednesday 16 April I

Monday 14 April 2003

Prevention and Control of Cervical Cancer in the New Millenium,
an International Commitment

PLENARY SESSIONS

These sessions are designed to present the most recent developments in cervical prevention, offering scientific excellence in the fields of screening, management and prevention, including emerging technologies, modern practice, and vaccine developments which are likely to improve or change clinical practice.
They are designed to bring together the main contributors to cervical cancer prevention, including experts and representatives of scientific societies, health organisations, women’s health institutions and decision-makers responding to the needs of patients, providers and public health authorities. An international charter aimed putting forward the priorities and directions to be taken to control the disease worldwide will be presented.


PS1 INTEGRATING EVIDENCE-BASED MEDICINE INTO CLINICAL PRACTICE
	Chairs :T. Wright (USA), E. Franco (Canada) • Cervical Cancer control, from past to present to future F. Montz (USA) • Epidemiological evidence for the role of HPV in cervical cancer X. Bosch (Spain) • Molecular evidence for HPV carcinogenesis A. Lorincz (USA) • Cervical Cancer Screening, facing the reality in the world M. Parkin (France) • New screening methods, challenging the success R. Richart (USA) • Managing abnormal PAP, current practice protocols T. Cox (USA)


PS2 THE PATIENT: A WISE CONSUMER
	Chairs : J. Austoker (UK), F. May Lewin (France) • Women against cervical cancer L. Alexander (USA)


PS3 THE ROLE OF DECISION MAKERS AND INSTITUTIONS
	Chairs : A. Miller (Germany), L. Abenhaim* (France) • Impact of health economies E. Myers (France) • The consensus conferences T. Wright (USA) • Role of International Health Organisation and NGO A. Miller (Germany)


PS4 ACCREDITATION, CERTIFICATION, QUALITY SCIENCE EVALUATION PROGRAMS
	Chairs : H.W. Lawson (USA), P. Walker (UK) • The rationale H.W. Lawson (USA) • Colposcopy: how it should be taught? A. Singer (UK) • Colposcopy: who should perform it? H. Kitchener (UK) • Cytopathology issues A.Verhest (Belgium), J. Linder (USA), A. Meisels (Canada) • Evaluation programmes H W. Lawson (USA), J. Patnick (UK)

PS5 INNOVATION IN HIGH PERFORMANCE COMMUNICATION SYSTEMS

Chairs : L. Alexander (USA), G. Brugal* (France)
• Telecolposcopy D. G. Ferris (USA)
• Telecytopathology
• Health on the net C. Boyer (Switzerland)
• Communicating with the patients J. Austoker (UK)


PS6 MANAGEMENT PROTOCOLES OF CERVICAL NEOPLASIA
PS6-1 DIAGNOSIS OF CIN
	Chairs : S. Dexeus (Spain), J. Jordan (UK) • The Bethesda System 2001 T. Wright (USA) • ASCUS T. Wright (USA) • L. SIL E. Wilkinson (USA) • H. SIL/ADC T. Cox (USA) • Early Invasion E. Diakomanolis (Greece)
PS6-2 THE PRACTICALITY OF MANAGEMENT PROTOCOLS WORLDWIDE: AN INTERNATIONAL FORUM
	Chairs : S. Dexeus (Spain), J. Jordan (UK) • International Federation of Colposcopy and Cervical Pathology (IFCCP) S. Dexeus (Spain) • European Federation of Colposcopy (EFC) J. Jordan (UK) • American Society of Colposcopy and Cervical Pathology (ASCCP) H. Jones (USA)


PS7 CONCLUSIONS: CERVICAL CANCER CONTROL, PRIORITIES AND NEW DIRECTIONS
	Chairs :R. Richart (USA), P. Lopes (France) • HPV C. Meijer (Netherlands) T. Cox (USA) • Epidemiology X. Bosch (Spain) E. Franco (Canada) • Cytopathology E. Mc Googan (UK) J. Linder (USA) • Colposcopy/Management A. Singer (UK) J. Monsonego (France) • Screening T. Wright (USA) R. Sankaranarayanan (F) • Vaccines J. Schiller (USA) P. Coursaget (France),I. Frazer (Australia)

Congress Secretariat
VBCE – EUROGIN – C. Cabotin
33, rue de l’Abbé Groult, 75015 Paris - France
Tel. +33 (0)1 45 33 60 46
Fax +33 (0)1 45 33 57 15
admin@eurogin.com

Scientific Secretariat
EUROGIN
174, rue de Courcelles, 75017 Paris -France
Tel. +33 (0)1 44 40 01 20
Fax +33 (0)1 47 66 74 70
admin@eurogin.com